Volume 15, Number 3—March 2009
Dispatch
Crimean-Congo Hemorrhagic Fever Virus in High-Risk Population, Turkey
Table 1
Characteristic | Persons living in rural area (n = 782) | Persons living in urban area (n = 100) |
---|---|---|
Age, y | ||
Mean ± SD | 41.5 ± 18.6 | 41.9 ± 18.4 |
Range |
7–83 |
7–80 |
Gender, no. (%) | ||
Female | 390 (49.8) | 53 (53) |
Male |
392 (50.2) |
47 (47) |
Total seroprevalence, no. positive (%) |
100 (12.8) |
2 (2) |
Seroprevalence by gender, no. positive/no. tested (%)† | ||
Female | 47/390 (12.1) | 0/53 (0) |
Male |
53/392 (13.5) |
2/47 (4.3) |
Seroprevalence by age, y, no. positive/no. tested (%)‡ | ||
7–20 | 4/138 (2.9) | 0/14 (0) |
21–30 | 9/100 (9) | 0/18 (0) |
31–40 | 14/134 (10.5) | 0/15 (0) |
41–50 | 20/126 (15.90 | 1/18 (5.6) |
51–60 | 23/157 (14.6) | 1/17(5.9) |
61–70 | 20/85 (23.5) | 0/13 (0) |
71–83 | 10/45 (22.2) | 0/5 (0) |
*CCHFV, Crimean-Congo hemorrhagic fever virus.
†p value = 0.59 for persons living in rural area; for persons living in urban area, data are insufficient for statistical analysis.
‡p value <0.001 for persons living in rural area; for persons living in urban area, data are insufficient for statistical analysis.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.